Derivatized oligonucleotides having improved uptake and other properties
AssigneeIsis Pharmaceuticals, Inc.
InventorsMuthiah Manoharan, Phillip Dan Cook, Clarence Frank Bennett
Life of this patent
Estimating the term…
Loading patent…
AssigneeIsis Pharmaceuticals, Inc.
InventorsMuthiah Manoharan, Phillip Dan Cook, Clarence Frank Bennett
Estimating the term…
Linked nucleosides having at least one functionalized nucleoside that bears a substituent such as a steroid molecule, a reporter molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, an RNA cleaving complex, a metal chelator, a porphyrin, an alkylator, a pyrene, a hybrid photonuclease/intercalator, or an aryl azide photo-crosslinking agent exhibit increased cellular uptake and other properties. The substituent can be attached at the 2′-position of the functionalized nucleoside via a linking group. If at least a portion of the remaining liked nucleosides are 2′-deoxy-2′-fluoro, 2′-O-methoxy, 2′-O-ethoxy, 2′-O-propoxy, 2′-O-aminoalkoxy or 2′-O-allyloxy nucleosides, the substituent can be attached via a linking group at any of the 3′ or the 5′ positions of the nucleoside or on the heterocyclic base of the nucleoside or on the inter-nucleotide linkage linking the nucleoside to an adjacent nucleoside.
A compound comprising a plurality of linked nucleosides, wherein:
A compound comprising a plurality of linked nucleosides, wherein:
A compound comprising a plurality of linked nucleosides, wherein:
Dependencies are inferred from the claim text.